SCHEMBL4128811

SCHEMBL4128811

COC(=O)C(C)(C)OCC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.39
CTH P32929 1/20 0.39
CBS P35520 1/20 0.39
THPO P40225 1/20 0.39
THRB P10828 1/20 0.37
DGAT1 O75907 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.33
KCNN4 O15554 1/20 0.33
HMGCR P04035 1/20 0.32
CHRM1 P11229 1/20 0.32
TBXA2R P21731 1/20 0.32
ADRA1A P35348 1/20 0.32
TP53 P04637 1/20 0.32
RAB9A P51151 1/20 0.32
EGLN1 Q9GZT9 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015627 0.82 MGAM (0.37) DGAT1SMN1; SMN2TP53RAB9ALMNA
SCHEMBL2039281 0.78 ALDH1A1 (0.34) DGAT1TP53RAB9A
SCHEMBL445544 0.76 DGAT1 (0.39) TSHRTHRBDGAT1SMN1; SMN2KCNN4
SCHEMBL6024452 0.76 TSHR (0.36) TSHRCTHCBSTHPOTHRB
SCHEMBL11513147 0.75 TSHR (0.36) TSHRDGAT1SMN1; SMN2HMGCRCHRM1
SCHEMBL27477394 0.74 TSHR (0.35) TSHRCTHCBSTHPOTHRB
SCHEMBL4122648 0.74 KCNN4 (0.31) TSHRCTHCBSTHPOTHRB
SCHEMBL13391665 0.73 CYP4F2 (0.37) TSHRDGAT1SMN1; SMN2TP53RAB9A
SCHEMBL10359638 0.73 CYP4F2 (0.41) TSHRDGAT1SMN1; SMN2KCNN4TP53
SCHEMBL10231407 0.73 TSHR (0.33) TSHRCTHCBSTHPOTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR TSHR 1672/4885CTH 186/4885CBS 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.